The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-2-amino-3-(4-(5-(4-((7-(3-hydroxypropylthio)-4-isobutyl-2-methyl-1-oxo-1H-pyrrolo[3,4-d]pyridazin-6(2H)-yl)methyl)naphthalen-1-yl)pent-4-ynyloxy)phenyl)propanoic acid ID: ALA3818150
PubChem CID: 127053099
Max Phase: Preclinical
Molecular Formula: C39H44N4O5S
Molecular Weight: 680.87
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)Cc1nn(C)c(=O)c2c(SCCCO)n(Cc3ccc(C#CCCCOc4ccc(C[C@H](N)C(=O)O)cc4)c4ccccc34)cc12
Standard InChI: InChI=1S/C39H44N4O5S/c1-26(2)22-35-33-25-43(38(49-21-9-19-44)36(33)37(45)42(3)41-35)24-29-16-15-28(31-11-6-7-12-32(29)31)10-5-4-8-20-48-30-17-13-27(14-18-30)23-34(40)39(46)47/h6-7,11-18,25-26,34,44H,4,8-9,19-24,40H2,1-3H3,(H,46,47)/t34-/m0/s1
Standard InChI Key: LBYOYODWKQFCFL-UMSFTDKQSA-N
Molfile:
RDKit 2D
49 53 0 0 0 0 0 0 0 0999 V2000
-6.4133 -6.8760 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.1764 -5.5904 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.4385 -4.2619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8936 -6.8644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1714 -5.5451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9345 -4.2596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9443 -3.1417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5870 -3.7544 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.7158 -5.2111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2779 -7.8944 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-7.1996 -2.9687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.7004 -2.9802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.3090 -1.9460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.2921 -4.0242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.0029 -7.9211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5797 -6.1883 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.1630 -5.6929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9749 -6.6715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3917 -6.1761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3015 -6.9585 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2907 -2.9981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2876 2.9981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2787 4.4989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2698 5.9997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0340 6.7432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0429 8.2440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3466 8.9875 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.3555 10.4883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6574 11.2333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6633 12.7333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3672 13.4884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0652 12.7435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0594 11.2435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3700 14.9892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0721 15.7428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0749 17.2437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9684 15.1451 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.1154 17.8414 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.9629 17.8462 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 1 0
2 3 2 0
3 6 1 0
5 4 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 1 0
9 5 2 0
4 10 2 0
3 11 1 0
11 12 1 0
12 13 1 0
12 14 1 0
1 15 1 0
9 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
8 21 1 0
21 22 1 0
22 27 1 0
26 23 1 0
23 24 2 0
24 25 1 0
25 22 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 26 2 0
23 32 1 0
32 33 3 0
33 34 1 0
34 35 1 0
35 36 1 0
36 37 1 0
37 38 1 0
38 39 2 0
39 40 1 0
40 41 2 0
41 42 1 0
42 43 2 0
43 38 1 0
41 44 1 0
44 45 1 0
45 46 1 0
45 47 1 6
46 48 1 0
46 49 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 680.87Molecular Weight (Monoisotopic): 680.3032AlogP: 5.77#Rotatable Bonds: 15Polar Surface Area: 132.60Molecular Species: ZWITTERIONHBA: 9HBD: 3#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 1.93CX Basic pKa: 9.47CX LogP: 4.11CX LogD: 4.10Aromatic Rings: 5Heavy Atoms: 49QED Weighted: 0.07Np Likeness Score: -0.38
References 1. Nair RN, Mishra JK, Li F, Tortosa M, Yang C, Doherty JR, Cameron M, Cleveland JL, Roush WR, Bannister TD.. (2016) Exploiting the co-reliance of tumours upon transport of amino acids and lactate: Gln and Tyr conjugates of MCT1 inhibitors., 7 (5): [PMID:27347360 ] [10.1039/c5md00579e ] 2. Wang Y, Qin L, Chen W, Chen Q, Sun J, Wang G.. (2021) Novel strategies to improve tumour therapy by targeting the proteins MCT1, MCT4 and LAT1., 226 [PMID:34517305 ] [10.1016/j.ejmech.2021.113806 ] 3. Murray, Clare M CM and 26 more authors. 2005-12 Monocarboxylate transporter MCT1 is a target for immunosuppression. [PMID:16370372 ] 4. Wang, Hui H and 5 more authors. 2014-09-11 Synthesis and structure-activity relationships of pteridine dione and trione monocarboxylate transporter 1 inhibitors. [PMID:25068893 ] 5. Nair, Reji N and 9 more authors. 2016-05-01 Exploiting the co-reliance of tumours upon transport of amino acids and lactate: Gln and Tyr conjugates of MCT1 inhibitors. [PMID:27347360 ]